MedPath

A cohort study on the effect of Tibetan medicine twenty-five-wei coral pill and Ruyi Zhenbao Pill on the recovery of neurological function after cerebral infarctio

Not Applicable
Conditions
Cerebral infarction
Registration Number
ITMCTR2000004073
Lead Sponsor
The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Aged 18-65 years old;
2. Meet the above diagnostic criteria of acute, convalescent and Tibetan medicine classification of cerebral infarction;
3. The vital signs are stable, conscious and able to express;
4. Be able to use mobile phone terminals or family members to cooperate with the use of evaluation; 5. Sign an informed consent form and agree to participate in this study; only those who meet the above five items can be selected.

Exclusion Criteria

1. Suffer from other serious somatic diseases, such as malignant tumor, severe infection, multiple organ failure, etc.
2.Patients with unstable vital signs;
3. Those with severe aphasia and agnosia are unable to communicate;
4. A person who is known to be alcoholic or materially dependent;
5. Patients with severe hepatic and renal insufficiency; those who meet one of the above items shall be excluded.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
mRS Scale;NIHSS Scale;Tibetan medicine scale;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath